Optimising anti-TNF treatment using biosimilars Learning Zone

Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.

This Learning Zone has been developed to provide practical advice and considerations on the use of biosimilars covering such topics as timely initiation, dose optimisation, the role of therapeutic drug monitoring, and cycling vs switching for anti-TNFs. The importance of shared decision-making to improve adherence and persistence are also discussed, as well as how biosimilars are shaping anti-TNF exit strategies.

 

Login/ Register Maximise Minimise

Alternatively login via